This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
3 Top Fertilizer Stocks That Your Portfolio Must Have for 2026
by Anindya Barman
After a 2024 slump, fertilizer prices rebounded in 2025, lifting margins. NTR, YARIY and IPI face higher costs but solid demand into 2026.
Nutrien Stock Rallies 40% YTD: What's Behind the Upside?
by Zacks Equity Research
NTR shares jump 40% YTD as strong global fertilizer demand, a higher potash outlook and rising cash flow fuel investor confidence.
Nutrien Closes Profertil Stake Sale, Advances Portfolio Strategy
by Zacks Equity Research
NTR completes $600M sale of its Profertil stake, advancing portfolio realignment and bolstering capital moves from growth to buybacks and debt cuts.
Why Is Nutrien (NTR) Up 8% Since Last Earnings Report?
by Zacks Equity Research
Nutrien (NTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Nutrien's Shares Rise 11% in a Month: What's Driving the Stock?
by Zacks Equity Research
NTR jumps as strong fertilizer demand, record potash sales and cost cuts fuel its outlook for 2025 growth.
Reasons Why You Should Hold Nutrien Stock in Your Portfolio Now
by Zacks Equity Research
NTR is riding strong fertilizer demand, cost cuts, and strategic deals despite pressure from rising input costs.
Can Nutrien's Cost Savings Drive Sustained Future Momentum?
by Zacks Equity Research
NTR's sharp Q3 expense cuts boost profitability and Retail margins, underscoring how cost discipline is strengthening its resilience in a mixed market.
NTR vs. CF: Which Fertilizer Giant is the Better Pick Now?
by Anindya Barman
Nutrien and CF Industries ride firm fertilizer demand, rising prices and stronger cash flow as global farm economics stay supportive.
Nutrien Stock Rises 27% YTD: What Should Investors Do Now?
by Anindya Barman
NTR's 27% YTD rally, rising fertilizer demand and cost cuts power its momentum even as input cost volatility lingers.
Nutrien's Earnings and Revenues Surpass Estimates in Q3, Up Y/Y
by Zacks Equity Research
NTR posts a sharp profit increase on stronger sales across segments and lifts Potash volume guidance for 2025.